Cempra Scores $10 Million

Cempra Pharmaceuticals Inc., a Morrisville, N.C.-based developer of anti-infectives, has raised $10 million in Series B funding, according to a regulatory filing. Backers include Aisling Capital, Intersouth Partners, Optimer Pharmaceuticals Inc. and banker I. Wistar Morris III. www.cempra.com